These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2576249

  • 1. Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
    Thomas KH, Vankrieken L.
    Int J Fertil; 1989 Sep; 34 Suppl():10-21. PubMed ID: 2576249
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
    Elomaa K, Lähteenmäki P.
    Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological and endocrine profiles of gestodene.
    Spona J, Huber J.
    Int J Fertil; 1987 Jul; 32 Suppl():6-14. PubMed ID: 2906347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ovarian activity during regular oral contraceptive use.
    Crosignani PG, Testa G, Vegetti W, Parazzini F.
    Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
    [Abstract] [Full Text] [Related]

  • 10. Effect of oral contraceptive containing a new progestin (ORG 2969) on plasma renin activity, growth hormone and immunoreactive insulin.
    Liukko P, Erkkola R, Lammintausta R.
    Ann Chir Gynaecol; 1979 Nov; 68(5-6):155-9. PubMed ID: 161858
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
    Duijkers IJ, Klipping C, Verhoeven CH, Dieben TO.
    Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
    [Abstract] [Full Text] [Related]

  • 13. [Inhibition of ovarian function using a triphasic combination with gestodene].
    Rozenbaum H.
    Rev Fr Gynecol Obstet; 1988 Jun 15; 83(6):449-52. PubMed ID: 3406638
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The low dosis gestagen therapy (author's transl)].
    Mall-Haefeli M, Ludwig KS, Spornitz UM, Uettwiller A.
    Geburtshilfe Frauenheilkd; 1976 Aug 15; 36(8):645-60. PubMed ID: 976705
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity.
    Sullivan H, Furniss H, Spona J, Elstein M.
    Fertil Steril; 1999 Jul 15; 72(1):115-20. PubMed ID: 10428158
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.